Cerecor (CERC) Reports Q2 Loss of $0.41/Share

Cerecor (NASDAQ: CERC) reported Q2 EPS of ($0.41), versus ($4.48) reported last year.

As of June 30, 2016, Cerecor’s cash and cash equivalents totaled $11.9 million, compared to $21.2 million at December 31, 2015. This decrease resulted from the funding of our research and development activities, our ongoing operations, and payments made on our term loan.

For earnings history and earnings-related data on Cerecor (CERC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat